109 related articles for article (PubMed ID: 1672520)
41. Thermodynamics of the anthracycline-nuclei interactions in drug-resistant and drug-sensitive K562 cells.
Tarasiuk J; Garnier-Suillerot A
Biochem Pharmacol; 1992 Jun; 43(12):2575-80. PubMed ID: 1632816
[TBL] [Abstract][Full Text] [Related]
42. Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP).
Lehne G; Mørkrid L; den Boer M; Rugstad HE
Int J Clin Pharmacol Ther; 2000 Apr; 38(4):187-95. PubMed ID: 10783828
[TBL] [Abstract][Full Text] [Related]
43. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein.
Essodaigui M; Broxterman HJ; Garnier-Suillerot A
Biochemistry; 1998 Feb; 37(8):2243-50. PubMed ID: 9485370
[TBL] [Abstract][Full Text] [Related]
44. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
Yusa K; Tsuruo T
Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
[TBL] [Abstract][Full Text] [Related]
45. Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines.
Takeshita H; Gebhardt MC; Springfield DS; Kusuzaki K; Mankin HJ
J Bone Joint Surg Am; 1996 Mar; 78(3):366-75. PubMed ID: 8613443
[TBL] [Abstract][Full Text] [Related]
46. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation.
Sharom FJ; Lu P; Liu R; Yu X
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):621-30. PubMed ID: 9677321
[TBL] [Abstract][Full Text] [Related]
47. The Effects of Iodinated Radiographic Contrast Media on Multidrug-resistant K562/Dox Cells: Mitochondria Impairment and P-glycoprotein Inhibition.
Supawat B; Udomtanakunchai C; Kothan S; Tungjai M
Cell Biochem Biophys; 2019 Jun; 77(2):157-163. PubMed ID: 30924055
[TBL] [Abstract][Full Text] [Related]
48. P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer.
Shapiro AB; Corder AB; Ling V
Eur J Biochem; 1997 Nov; 250(1):115-21. PubMed ID: 9431998
[TBL] [Abstract][Full Text] [Related]
49. Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells.
Chiodini B; Bassan R; Barbui T
Leuk Lymphoma; 1999 May; 33(5-6):485-97. PubMed ID: 10342576
[TBL] [Abstract][Full Text] [Related]
50. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
Horio M; Lovelace E; Pastan I; Gottesman MM
Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
[TBL] [Abstract][Full Text] [Related]
51. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
[TBL] [Abstract][Full Text] [Related]
52. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185----Val-185 substitution in P-glycoprotein.
Safa AR; Stern RK; Choi K; Agresti M; Tamai I; Mehta ND; Roninson IB
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7225-9. PubMed ID: 1976255
[TBL] [Abstract][Full Text] [Related]
53. The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.
Spoelstra EC; Westerhoff HV; Pinedo HM; Dekker H; Lankelma J
Eur J Biochem; 1994 Apr; 221(1):363-73. PubMed ID: 7909520
[TBL] [Abstract][Full Text] [Related]
54. Enhancement of activities of anti-tumor drugs by dipyridamole against multidrug-resistant human hepatoma PLC/PRF/5 cells.
Tatsuta T; Shimizu K; Nishimura T; Suzuki H
Anticancer Drug Des; 1991 Jul; 6(3):179-88. PubMed ID: 1678605
[TBL] [Abstract][Full Text] [Related]
55. Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
Lehne G; De Angelis P; Clausen OP; Rugstad HE
Br J Cancer; 1996 Dec; 74(11):1719-29. PubMed ID: 8956784
[TBL] [Abstract][Full Text] [Related]
56. Steroid hormones inhibit binding of Vinca alkaloid to multidrug resistance related P-glycoprotein.
Naito M; Yusa K; Tsuruo T
Biochem Biophys Res Commun; 1989 Feb; 158(3):1066-71. PubMed ID: 2563940
[TBL] [Abstract][Full Text] [Related]
57. Accumulation of degradation products of doxorubicin and pirarubicin formed in cell culture medium within sensitive and resistant cells.
Fiallo M; Laigle A; Borrel MN; Garnier-Suillerot A
Biochem Pharmacol; 1993 Feb; 45(3):659-65. PubMed ID: 8095138
[TBL] [Abstract][Full Text] [Related]
58. Novel mechanism of N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine in potentiation of antitumor drug action on multidrug-resistant and sensitive Chinese hamster cells.
Tomida A; Tatsuta T; Suzuki H
Jpn J Cancer Res; 1991 Jan; 82(1):127-33. PubMed ID: 1671855
[TBL] [Abstract][Full Text] [Related]
59. Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein.
Shapiro AB; Ling V
Eur J Biochem; 1997 Nov; 250(1):122-9. PubMed ID: 9431999
[TBL] [Abstract][Full Text] [Related]
60. Use of membrane vesicles to investigate drug interactions with transporter proteins, P-glycoprotein and multidrug resistance-associated protein.
Wheeler R; Neo SY; Chew J; Hladky SB; Barrand MA
Int J Clin Pharmacol Ther; 2000 Mar; 38(3):122-9. PubMed ID: 10739115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]